Kathleen Weisel
Impact in
-
- Inflammatory Bowel Disease
-
- Cell death mechanisms and regulation
- Inflammasome and immune disorders
Papers in
-
- Multiple Myeloma Research and Treatments 2
- Platelet Disorders and Treatments 1
-
- Psoriasis: Treatment and Pathogenesis 1
- Immunotoxicology and immune responses 1
- Co-authors
- Debra J. Tompson (3 shared papers)John Bertin (2 shared papers)Scott B. Berger (2 shared papers)Monica Simeoni (2 shared papers)Paul Peter Tak (2 shared papers)Nicola E. Scott (2 shared papers)Zijiang Yang (1 shared paper)Remo Panaccione (1 shared paper)
- Journals
- Gastroenterology (1 paper)Journal of the American Heart Association (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Human Vaccines & Immunotherapeutics (1 paper)Pharmacology Research & Perspectives (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Kathleen Weisel
8 papers receiving 441 citations
Kathleen Weisel's Hit Papers
Peers
Comparison fields: 5 of 44
- Genetics 138
- Molecular Biology 198
- Hematology 30
- Immunology 43
- Immunology and Allergy 9
Countries citing papers authored by Kathleen Weisel
This map shows the geographic impact of Kathleen Weisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Weisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Weisel more than expected).
Fields of papers citing papers by Kathleen Weisel
This network shows the impact of papers produced by Kathleen Weisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Weisel. The network helps show where Kathleen Weisel may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathleen Weisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study Hit paper breakdown → | 2022 | 158 |
| 2 | 2017 | 117 | |
| 3 | 2021 | 72 | |
| 4 | 2020 | 68 | |
| 5 | 2013 | 30 | |
| 6 | 2025 | 7 | |
| 7 | HIGH CUT-OFF HAEMODIALYSIS (HCO-HD) DOES NOT IMPROVE OUTCOMES IN MYELOMA CAST NEPHROPATHY: RESULTS OF EUROPEAN TRIAL OF FREE LIGHT CHAIN REMOVAL BY EXTENDED HAEMODIALYSIS IN CAST NEPHROPATHY (EULITE) | 2016 | 6 |
| 8 | 2015 | 1 |
About Kathleen Weisel
Kathleen Weisel is a scholar working on Hematology, Immunology, Statistics and Probability, Rheumatology and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 459 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (2 papers), Cell death mechanisms and regulation (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Statistical Methods in Clinical Trials (1 paper), Platelet Disorders and Treatments (1 paper), Psoriasis: Treatment and Pathogenesis (1 paper) and Immunotoxicology and immune responses (1 paper). The work is most often cited by research in Genetics (138 citations), Molecular Biology (198 citations), Hematology (30 citations), Immunology (43 citations) and Immunology and Allergy (9 citations). Kathleen Weisel has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Debra J. Tompson, John Bertin, Scott B. Berger, Monica Simeoni, Paul Peter Tak, Nicola E. Scott, Zijiang Yang, Remo Panaccione, Bruce E. Sands and William J. Sandborn. Their work appears in journals such as Gastroenterology, Journal of the American Heart Association, Clinical Pharmacology & Therapeutics, Human Vaccines & Immunotherapeutics and Pharmacology Research & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.